Synapse Open Synapse
Biology

Cardiovascular–kidney–metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy

Frontiers Cell & Developmental Biology · · 53 min read

Cardiovascular–kidney–metabolic (CKM) syndrome represents a systemic disease continuum arising from the progressive and reciprocal interactions among metabolic dysfunction, kidney injury, and cardiovascular disease.

Latest from Frontiers Cell & Developmental Biology